This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

British Journal of Clinical Pharmacology


Effect of rifampin on enantioselective disposition and anti‐hypertensive effect of benidipine

Pages: 737-745

Article date: April 2019

Authors: Yu Eun Sunwoo, Phuong Thi Thu Nguyen, Chin May Chien, Ji Young Ryu, Jihong Shon, Jae‐Gook Shin

Cefuroxime plasma and tissue concentrations in patients undergoing elective cardiac surgery: Continuous vs bolus application. A pilot study

Pages: 818-826

Article date: April 2019

Authors: Keso Skhirtladze‐Dworschak, Doris Hutschala, Georg Reining, Peter Dittrich, Anna Bartunek, Martin Dworschak, Edda M. Tschernko

Optimising infliximab induction dosing for patients with ulcerative colitis

Pages: 782-795

Article date: April 2019

Authors: Erwin Dreesen, Ruben Faelens, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ann Gils, Thomas Bouillon

A phase 1b randomized, placebo‐controlled clinical trial with SNF472 in haemodialysis patients

Pages: 796-806

Article date: April 2019

Authors: Carolina Salcedo, Pieter H. Joubert, Miguel D. Ferrer, Ana Z. Canals, Francisco Maduell, Vicens Torregrosa, Josep Maria Campistol, Raquel Ojeda, Joan Perelló

Paediatric extrapolation: the panacea for paediatric drug development?

Pages: 672-674

Article date: April 2019

Authors: John Anker

Discontinuation of medications at the end of life: A population study in Belgium, based on linked administrative databases

Pages: 827-837

Article date: April 2019

Authors: Kristel Paque, Robrecht De Schreye, Monique Elseviers, Robert Vander Stichele, Koen Pardon, Tinne Dilles, Thierry Christiaens, Luc Deliens, Joachim Cohen

Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report

Pages: 690-703

Article date: April 2019

Authors: Thitiporn Supasitthumrong, Blanca M. Bolea‐Alamanac, Selim Asmer, Vincent L. Woo, Petal S. Abdool, Simon J.C. Davies

Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo‐controlled, phase I study in healthy volunteers

Pages: 762-770

Article date: April 2019

Authors: Li‐Ming Gan, Maria Lagerström‐Fermér, Hans Ericsson, Karin Nelander, Eva‐Lotte Lindstedt, Erik Michaëlsson, Magnus Kjaer, Maria Heijer, Carl Whatling, Rainard Fuhr